Skip to content
Research Article Open access CC BY 4.0

Epidemiology of Vaginal candidiasis and Its Antifungal Susceptibility Pattern at the Buea Regional Hospital in Cameroon

Nicoline Fri Tanih, Leudja Nathalie Flore, Luma Woquan Sama, Ofon Elvis Amih, Tanih Godfred Ngu, Samie Amidou, Chethkwo Fabrice, Njunda Anna Longdoh

International Journal of TROPICAL DISEASE & Health · pp. 68–79 · Published 20 Jun 2024

10.9734/ijtdh/2024/v45i71561

Abstract

Aims: This study aimed to assess the prevalence of Vulvovaginal candidiasis (VVC) and investigate the antifungal susceptibility patterns among both pregnant and non-pregnant women in Buea, Cameroon. Study Design:  Cross-sectional hospital-based design. Place and Duration of Study: The study was conducted at the Buea Regional Hospital, in the South West Region of Cameroon for a period of 3months. Methodology: The study included a total of 270 participants, comprising 135 pregnant women and 135 non-pregnant women. Vaginal swab samples were collected and cultured on Sabouraud Dextrose Agar supplemented with chloramphenicol and later sub-cultured on Chromogenic Candida Agar. A Germ tube test was carried out to confirm the presence of Candida albicans and served as a confirmatory test in classifying the species as pathogenic or not. Kirby-Bauer disk diffusion technique was used for antimicrobial susceptibility testing. Statistical analysis was performed where a P <0.05 was considered significant. Results: The overall prevalence of VVC was 20.7%. The prevalence was higher among pregnant women (23.7%) compared to non-pregnant women (17.8%). Candida albicans 69.6% was the most prevalent species while C. tropicalis (5.4%) was the least. Predisposing factors such as history of candidiasis was associated with VVC in pregnant women (P=0.009), while the presence of symptoms (P=0.011), and clothing preferences like trousers (P=0.048) were associated with VVC in non-pregnant women. Voriconazole (66.15%) was the most effective antifungal drug while caspofungin (81.25%) was least effective to all species. Conclusion: VVC has a higher prevalence in pregnant than in non-pregnant women with Candida albicans, being the most prevalent species. History of candidiasis, presence of symptoms, and clothing preferences like trousers were statistically associated with the presence of VVC in this study population. Voriconazole could serve as the drug of choice for management of VVC infection.

Vulvovaginal candidiasis pregnant and non-pregnant women predisposing factors

References (27)

  1. 1 Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations [DOI]
  2. 2 Global burden of recurrent vulvovaginal candidiasis: a systematic review [DOI]
  3. 3 Recurrent vulvovaginal candidiasis [DOI]
  4. 4 Cell biology of Candida albicans–host interactions [DOI]
  5. 5 Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates [DOI]
  6. 6 Prevalence and Risk Factors of Vulvovaginal Candidosis during Pregnancy: A Review [DOI]
  7. 7 Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion [DOI]
  8. 8 Prevalence, risk factors and antifungal susceptibility pattern of Candida species among pregnant women at Debre Markos Referral Hospital, Northwest Ethiopia [DOI]
  9. 9 Recurrent vulvovaginal candidiasis: A review of guideline recommendations [DOI]
  10. 10 Sensitivity of Vaginal Isolates of Candida to Eight Antifungal Drugs Isolated From Ahvaz, Iran [DOI]
  11. 11 Recent advances on Candida albicans biology and virulence [DOI]
  12. 12 Prevalence of Vaginal Candidiasis among Pregnant Women in Nnewi Town of Anambra State, Nigeria [DOI]
  13. 13 Recurrent vulvovaginal candidosis among young women in south eastern Nigeria: the role of lifestyle and health-care practices [DOI]
  14. 14 Candida antifungal drug resistance in sub-Saharan African populations: A systematic review [DOI]
  15. 15 Symptomatic vulvovaginal candidiasis and genital colonization by Candida species in Nigeria [DOI]
  16. 16 Candida vulvovaginitis in pregnancy [DOI]
  17. 17 Prevalence of asymptomatic Co-Infection of Candidiasis and Vaginal Trichomoniasis among Pregnant Women in Abakaliki, South-Eastern Nigeria
  18. 18 Assessment of Risk Factors for Developing Vulvovaginal Candidiasis Among Women at Various Age Groups [DOI]
  19. 19 Prevalence and comparison for detection methods of Candida species in vaginal specimens from pregnant and non pregnant Saudi women [DOI]
  20. 20 Prevalence of vaginal candidiasis among pregnant women with abnormal vaginal discharge in Maiduguri.
  21. 21 Antifungal profile of vulvovaginal candidiasis in sexually active females from a tertiary care hospital of Western Rajasthan [DOI]
  22. 22 Housing Standards, Household Health and Disease Nexus in the Buea Municipality [DOI]
  23. 23 Recurrent Vulvovaginal Candidiasis [DOI]
  24. 24 Antifungal susceptibility profiles and risk factors of vaginal candidiasis amongst female university students in southwest region, Cameroon [DOI]
  25. 25 Antibiogram of Vulvovaginal Candidiasis amongst Pharmacy Undergraduates in a Nigerian University [DOI]
  26. 26 Screening and Risk Factor Associated with Vulvovaginal Candidiasis among Pregnant Women [DOI]
  27. 27 Quality of Life Among Women with Vulvovaginal Candidiasis in a Tertiary Care Centre in India [DOI]

Cited by 4

Vulvo-vaginal candidiasis at the Zion Clinical Laboratory (Yaounde-Cameroon): risk factors, species distribution and antifungal susceptibility testing

Thierry Kammalac Ngouana, Aude Ngueguim Dougue, Vincent Ngouana · Journal de Mycologie Médicale · 2025

Antifungal resistance profile of Candida species involved in vulvovaginal candidiasis infections in pregnant women in the Buea Regional Hospital, Cameroon

Etone Nkwelle Cathybless Dione, Elisabeth Zeuko’o Menkem, Eléonore Ngounou · Discover Public Health · 2026

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

23

Page views

0

PDF downloads

10

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.